A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Epoprostenol has been studied across 14 research domains including 🫁 Respiratory, ❤️ Cardiovascular, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox. The primary research focus is 🫁 Respiratory with 78% of studies addressing this area.
The following compounds share molecular targets with Epoprostenol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Epoprostenol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.